CRISPR technology has radically transformed genetic research, and at the forefront of this transformation is CRISPR screening ...

As translational CRISPR-based research continues to make waves in laboratories and the clinic, scientists across life science disciplines pursue out-of-the-ordinary genome editing applications. From ...

It’s a new way to create “bi-paternal” mice that can survive to adulthood—but human applications are still a long way off.

9 In addition to its application in infectious diseases, there are several CRISPR-based developments for the diagnosis of other diseases, including cancer, where it is being used to detect cancer ...

This study presents an optimized CRISPR-Cas12a system for large-scale genetic screening, revealing critical genes involved in ...

CRISPR-Cas9 genome editing exploits the CRISPR ... highlighting its potential as an efficient and precise tool for gene editing applications. Establishment and robust expansion of human fetal ...

Australian researchers have successfully introduced an improved version of Cas12a gene-editing enzyme in mice.

Akribion Therapeutics emerges from stealth with €8 million in seed funding to develop a novel cancer RNA-guided approach ...

CRISPR & Cas Genes Market Growing funding in gene therapy worldwide is a prominent factor driving the CRISPR & Cas genes market.

CRISPR Therapeutics' stock decline is likely influenced by Editas Medicine's struggles, but CRISPR remains a distinct and stronger company with a promising long-term outlook. CRISPR's strategic ...

Interested organisations can verify their eligibility and submit their application through ERS ... streamlines and accelerates access to CRISPR/Cas9, making it more affordable than ever for ...